Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-03

FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA has approved Glenmark Pharmaceuticals Inc., USA's supplemental application for Lithium carbonate (generic) under ANDA 079139. The approval updates the statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE (LITHIUM CARBONATE)